Lite Strategy LITS
NASDAQ LITS
$1.16 -0.03 (-2.52%)
At close: Oct 23, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Return on Sales [ROS] (2016 - 2024)

Updated

Lite Strategy's Return on Sales [ROS] came in at 22.27% for fiscal Q4 2024 (quarter ended Jun 30, 2024), up 782.74 percentage points from -760.47% a year earlier but down 11.35 percentage points from the prior quarter.

Analysis

Lite Strategy (LITS) Return on Sales [ROS] (2016 - 2024) Analysis & Trends

Going back to fiscal Q1 2017, Lite Strategy's Return on Sales [ROS] data covers 32 quarters.

  • Return on Sales [ROS] carries a five-year change of +963.17 percentage points (FY2019 to FY2024).
  • Going back by fiscal year, Return on Sales [ROS] was -75.31% in FY2023 (+110.17 pp), -185.48% in FY2022 (-11.83 pp), -173.65% in FY2021 (-81.07 pp) and -92.58% in FY2020 (+848.31 pp).
  • The five-year range for quarterly Return on Sales [ROS] is -1201.29% (fiscal Q2 2020) to 84.66% (fiscal Q1 2024).
  • Year-over-year, Return on Sales [ROS] increased in five of the last eight quarters, with an average year-over-year change of +116.85 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in fiscal Q4 2020 (a gain of 1085.57 percentage points), and the weakest in fiscal Q2 2020 (a drop of 623.06 percentage points).
  • Business Quant data shows LITS's Return on Sales [ROS] at 33.62% (Q3 2024), 21.86% (Q2 2024) and 84.66% (Q1 2024) in the three fiscal quarters before Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 24.35%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 37.86%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -3.52%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 20.57%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 28.37%
10 Lite Strategy 40.43 Mn 8.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 22.27%
Mar 31, 2024 33.62%
Dec 31, 2023 21.86%
Sep 30, 2023 84.66%
Jun 30, 2023 -760.47%
Mar 31, 2023 -278.10%
Dec 31, 2022 27.27%
Sep 30, 2022 -208.69%
Jun 30, 2022 -141.90%
Mar 31, 2022 -222.38%
Dec 31, 2021 -148.96%
Sep 30, 2021 -259.19%
Jun 30, 2021 -207.59%
Mar 31, 2021 -202.18%
Dec 31, 2020 -125.23%
Sep 30, 2020 -192.56%
Jun 30, 2020 45.00%
Mar 31, 2020 -1,000.24%
Dec 31, 2019 -1,201.29%
Sep 30, 2019 -1,091.01%
API Access

Lite Strategy Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=LITS&period=max&api_key=YOUR_API_KEY